FDA Approves Novel Prostate Cancer “Vaccine”

FDA Approves Novel Prostate Cancer “Vaccine”
The treatment, which works by turning the body’s immune system against invading cancer cells, is called Provenge and is manufactured by Seattle biotech firm Dendreon

Read more on Time Magazine

Related posts

Experimental vaccine can help delay IBD and colon cancer

Experimental vaccine can help delay IBD and colon cancer
An experimental vaccine against an abnormal protein found in some tumors has the potential to delay the onset of inflammatory bowel disease (IBD) and in turn prevent progression to colon cancer, according to researchers at the University of Pittsburgh School of Medicine.

Read more on News-Medical-Net

Related posts

With Pancreatic Cancer, Age Factors Into Familial Risk

With Pancreatic Cancer, Age Factors Into Familial Risk
TUESDAY, Jan. 12 (HealthDay News) — People with a family member who had pancreatic cancer before age 50 face a greatly increased risk for the disease, a new study has found.

Read more on HealthDay via Yahoo! News

Related posts